Keren Kocshitzki
Director of Finance/CFO at FutuRx Ltd.
Profile
Keren Kocshitzki is currently the Director at GliXogen Therapeutics Ltd.
and the Chief Finance Officer at FutuRx Ltd.
She completed her undergraduate and graduate degrees at Ben-Gurion University of the Negev in 2000.
Keren Kocshitzki active positions
Companies | Position | Start |
---|---|---|
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Director of Finance/CFO | 30/04/2018 |
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Director/Board Member | 16/01/2019 |
Training of Keren Kocshitzki
Ben-Gurion University of the Negev | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
- Stock Market
- Insiders
- Keren Kocshitzki